Narachi Michael - Insider Stock Trading - OpenInsider

CIK: 1380022 - Address: C/o Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato, CA 94949

9 results

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
P	%ret	3	1	3	-0	-4	7	17	27	35	14
P	%wins				67	0	67	100	100	67	67
S	%ret	1	1	3	-1	-6	-27	-5	-7	-3	-8
S	%wins				67	67	100	67	100	33	72

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
9/15/14 14:41	9/15/14	OREX	Orexigen Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Narachi Michael	CA	DO	P,CEO	P	239	4.78	3	50	623	58	D	-1	-23	-26	-12	4	-10	-11	-12	-5	-8	-37	12	35	-51
2/6/14 15:50	2/4/14	CLDN	Celladon Corp	DE	Health	BioPrd	Biological Products, (No Diag	Narachi Michael	CA	D		P	500	8.00	4	63	New	63	D								-9	2	-2	49	31	37	109
7/19/12 20:07	7/17/12	OREX	Orexigen Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Narachi Michael	CA	DO	P,CEO	M.d	250	1.67	5	150		0	D	65	314	249	78	105	41	14	-2	-3	-11	-30	0	-4	2
7/19/12 20:07	7/17/12	OREX	Orexigen Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Narachi Michael	CA	DO	P,CEO	S.d	-1,149	7.66	5	-150	-100	0	D	65	314	249	78	105	41	14	-2	-3	-11	-30	0	-4	2
7/13/12 20:13	7/12/12	OREX	Orexigen Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Narachi Michael	CA	DO	P,CEO	M.dm	249	1.66	3	150		0	D	19	287	257	65	98	62	24	9	5	-11	-43	-17	-12	-15
7/13/12 20:13	7/12/12	OREX	Orexigen Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Narachi Michael	CA	DO	P,CEO	S.dm	-1,005	6.70	3	-150	-100	0	D	19	287	257	65	98	62	24	9	5	-11	-43	-17	-12	-15
6/29/12 18:58	6/28/12	OREX	Orexigen Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Narachi Michael	CA	DO	P,CEO	M.dm	374	1.66	2	225		0	D	40	273	269	30	65	75	51	45	-4	4	-7	3	-5	3
6/29/12 18:58	6/28/12	OREX	Orexigen Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Narachi Michael	CA	DO	P,CEO	S.dm	-1,326	5.89	2	-225	-100	0	D	40	273	269	30	65	75	51	45	-4	4	-7	3	-5	3
5/29/12 14:17	5/24/12	AMAG	Amag Pharmaceuticals Inc.	DE	Health	Drug	Pharmaceutical Preparations	Narachi Michael	MA	D		P.m	27	3.61	3	8	New	8	D	-57	-14	-16	-16	-11	-14	11	5	2	-1	9	8	8	48

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

Return to top

Contact